Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

RCPE UK consensus statement on diabetes.

Anderson A, Boyd K, Christie B, Claridge C, Currie P, Doherty T, Dorward D, Elder A, Hadley-Brown M, Hughes D, Jackson M, Jung R, Marshall S, MacKinnon M, Pollock A, Ritchie L.

J R Coll Physicians Edinb. 2010 Jun;40(2):130-1. doi: 10.4997/JRCPE.2010.S06. No abstract available.

PMID:
21125057
2.

The RCPE UK Consensus Statement on Diabetes.

Dunbar JA.

J R Coll Physicians Edinb. 2010 Sep;40(3):283; author reply 283. doi: 10.4997/JRCPE.2010.321. No abstract available.

PMID:
21127772
3.

Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic.

Robertson RP, Kendall DM, Seaquist ER.

Nat Rev Endocrinol. 2010 Mar;6(3):128-9. doi: 10.1038/nrendo.2010.2. No abstract available.

PMID:
20173772
4.

The continuing legacy of the United Kingdom Prospective Diabetes Study.

Davis TM, Colagiuri S; United Kingdom Prospective Diabetes Study.

Med J Aust. 2004 Feb 2;180(3):104-5. No abstract available.

PMID:
14748669
5.

The RCPE UK Consensus Statement on Diabetes opens up more questions.

Krishnaswami CV.

J R Coll Physicians Edinb. 2010 Sep;40(3):283-4; author reply 284-5. doi: 10.4997/JRCPE.2010.321. No abstract available.

PMID:
21127771
6.

Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.

Mansour AA, Habib OS.

Saudi Med J. 2007 Dec;28(12):1919-21. No abstract available.

PMID:
18060234
7.

Trends in the prevalence and incidence of diabetes in the UK: 1996-2005.

González EL, Johansson S, Wallander MA, Rodríguez LA.

J Epidemiol Community Health. 2009 Apr;63(4):332-6. doi: 10.1136/jech.2008.080382. Epub 2009 Feb 24. Erratum in: J Epidemiol Community Health. 2009 Oct;63(10):864.

PMID:
19240084
8.

[Metformin for prevention of diabetes?].

Göke B.

Internist (Berl). 2000 May;41(5):491. German. No abstract available.

PMID:
10867907
9.

[++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].

Janka HU.

Internist (Berl). 2000 Jul;41(7):688-9. Review. German. No abstract available.

PMID:
10929259
10.

[Metformin and type 2 diabetes: the UKPDS experience].

Leverve XM.

Journ Annu Diabetol Hotel Dieu. 2007:5-11. French. No abstract available.

PMID:
18610755
11.
12.

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.

Beale S, Bagust A, Shearer AT, Martin A, Hulme L.

Pharmacoeconomics. 2006;24 Suppl 1:21-34. Review.

PMID:
16800160
13.
14.

Diabetes: preventing type 2 diabetes mellitus: is metformin the answer?

Buchanan TA, Xiang AH.

Nat Rev Endocrinol. 2010 May;6(5):253-4. doi: 10.1038/nrendo.2010.25. No abstract available.

PMID:
20414319
15.

The treatment of type 2 diabetes: good news from the UK.

Smith RB, Mann JI.

N Z Med J. 1999 May 14;112(1087):149-50. No abstract available.

PMID:
10378808
16.

The renaissance of metformin in endocrine clinical practice.

Milewicz A, Sieradzki J, Tendera-Małecka E, Skałba P, Jedrzejuk D.

Gynecol Endocrinol. 2009 May;25(5):277-81. No abstract available.

PMID:
19903035
17.
18.

A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.

Tilden DP, Mariz S, O'Bryan-Tear G, Bottomley J, Diamantopoulos A.

Pharmacoeconomics. 2007;25(1):39-54. Erratum in: Pharmacoeconomics. 2007;25(3):237.

PMID:
17192117
19.

Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice.

Nichols GA, Conner C, Brown JB.

Curr Med Res Opin. 2010 Sep;26(9):2127-35. doi: 10.1185/03007995.2010.504396.

PMID:
20658898
20.

Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia.

McDonnell ME, Ruderman NB.

Diabetes Care. 1999 Nov;22(11):1912-3. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk